Jujuboside B Inhibits the Proliferation of Breast Cancer Cell Lines by Inducing Apoptosis and Autophagy

被引:12
作者
Guo, Lin [1 ,2 ]
Liang, Yupei [3 ]
Wang, Shiwen [4 ]
Li, Lihui [3 ]
Cai, Lili [3 ]
Heng, Yongqing [3 ]
Yang, Jing [3 ]
Jin, Xing [3 ]
Zhang, Junqian [3 ]
Yuan, Shuying [3 ]
Xu, Tong [3 ]
Jia, Lijun [1 ,3 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Canc Inst, Shanghai, Peoples R China
[2] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Canc Inst, Shanghai, Peoples R China
[4] Fudan Univ, Dept Lab Med, Huadong Hosp, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
jujuboside B; breast cancer; apoptosis; autophagy; NOXA; AMPK; TRADITIONAL CHINESE MEDICINE; AMPK; PHOSPHORYLATION; RESVERATROL; MECHANISMS; FLAVONOIDS; ENERGY;
D O I
10.3389/fphar.2021.668887
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Jujuboside B (JB) is one of the main biologically active ingredients extracted from Zizyphi Spinosi Semen (ZSS), a widely used traditional Chinese medicine for treating insomnia and anxiety. Breast cancer is the most common cancer and the second leading cause of cancer-related death in women worldwide. The purpose of this study was to examine whether JB could prevent breast cancer and its underlying mechanism. First, we reported that JB induced apoptosis and autophagy in MDA-MB-231 and MCF-7 human breast cancer cell lines. Further mechanistic studies have revealed that JB-induced apoptosis was mediated by NOXA in both two cell lines. Moreover, the AMPK signaling pathway plays an important role in JB-induced autophagy in MCF-7. To confirm the anti-breast cancer effect of JB, the interaction of JB-induced apoptosis and autophagy was investigated by both pharmacological and genetic approaches. Results indicated that autophagy played a pro-survival role in attenuating apoptosis. Further in vivo study showed that JB significantly suppressed the growth of MDA-MB-231 and MCF-7 xenografts. In conclusion, our findings indicate that JB exerts its anti-breast cancer effect in association with the induction of apoptosis and autophagy.
引用
收藏
页数:13
相关论文
共 51 条
[1]   MONITORING AUTOPHAGIC DEGRADATION OF P62/SQSTM1 [J].
Bjorkoy, Geir ;
Lamark, Trond ;
Pankiv, Serhiy ;
Overvatn, Aud ;
Brech, Andreas ;
Johansen, Terje .
METHODS IN ENZYMOLOGY: AUTOPHAGY IN MAMMALIAN SYSTEMS, VOL 452, PT B, 2009, 452 :181-197
[2]   The BCL2 family: Regulators of the cellular life-or-death switch [J].
Cory, S ;
Adams, JM .
NATURE REVIEWS CANCER, 2002, 2 (09) :647-656
[3]   Cell death: a review of the major forms of apoptosis, necrosis and autophagy [J].
D'Arcy, Mark S. .
CELL BIOLOGY INTERNATIONAL, 2019, 43 (06) :582-592
[4]   Breast cancer statistics, 2019 [J].
DeSantis, Carol E. ;
Ma, Jiemin ;
Gaudet, Mia M. ;
Newman, Lisa A. ;
Miller, Kimberly D. ;
Sauer, Ann Goding ;
Jemal, Ahmedin ;
Siegel, Rebecca L. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (06) :438-451
[5]   Mechanism and medical implications of mammalian autophagy [J].
Dikic, Ivan ;
Elazar, Zvulun .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2018, 19 (06) :349-364
[6]   Resveratrol: An overview of its anti-cancer mechanisms [J].
Elshaer, Mohamed ;
Chen, Yeru ;
Wang, Xiu Jun ;
Tang, Xiuwen .
LIFE SCIENCES, 2018, 207 :340-349
[7]   AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance [J].
Garcia, Daniel ;
Shaw, Reuben J. .
MOLECULAR CELL, 2017, 66 (06) :789-800
[8]   Cell Death Signaling [J].
Green, Douglas R. ;
Llambi, Fabien .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2015, 7 (12)
[9]   Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During and After Breast Cancer Treatment [J].
Greenlee, Heather ;
DuPont-Reyes, Melissa J. ;
Balneaves, Lynda G. ;
Carlson, Linda E. ;
Cohen, Misha R. ;
Deng, Gary ;
Johnson, Jillian A. ;
Mumber, Matthew ;
Seely, Dugald ;
Zick, Suzanna M. ;
Boyce, Lindsay M. ;
Tripathy, Debu .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (03) :195-232
[10]   AMPK-Sensing Energy while Talking to Other Signaling Pathways [J].
Hardie, D. Grahame .
CELL METABOLISM, 2014, 20 (06) :939-952